Bohen Sean
SEC insider (Form 3/4/5 filer). CIK 0001831218. PRESIDENT AND CEO at Olema Pharmaceuticals, Inc. (OLMA). 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 2, 2026. Located in SAN FRANCISCO, CA.
Companies Bohen Sean has filed insider reports for
- Olema Pharmaceuticals, Inc. (OLMA): Director, Officer, PRESIDENT AND CEO
Bohen Sean
CIK: 0001831218
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Olema Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Feb 2, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
850K shares- - Feb 2, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectPerformance Stock Options (Right to Buy)
275K shares- - Dec 26, 2025OLMA
Olema Pharmaceuticals, Inc.
GiftDirect8.5K shares- - Feb 28, 2025OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
650K shares- - Dec 11, 2024OLMA
Olema Pharmaceuticals, Inc.
SaleDirect55.9K shares at avg. $8.66$484K - Dec 11, 2024OLMA
Olema Pharmaceuticals, Inc.
SaleDirect1.3K shares at avg. $9.39$12K - Dec 10, 2024OLMA
Olema Pharmaceuticals, Inc.
SaleDirect52.3K shares at avg. $9.37$490K - Dec 9, 2024OLMA
Olema Pharmaceuticals, Inc.
AwardDirect204.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 850,000 | - | - | Direct |
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award Performance Stock Options (Right to Buy) | 275,000 | - | - | Direct |
| Dec 26, 2025 | OLMA Olema Pharmaceuticals, Inc. | Gift | 8,500 | - | - | Direct |
| Feb 28, 2025 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 650,000 | - | - | Direct |
| Dec 11, 2024 | OLMA Olema Pharmaceuticals, Inc. | Sale | 55,907 | $8.66 | $484,155 | Direct |
| Dec 11, 2024 | OLMA Olema Pharmaceuticals, Inc. | Sale | 1,267 | $9.39 | $11,897 | Direct |
| Dec 10, 2024 | OLMA Olema Pharmaceuticals, Inc. | Sale | 52,328 | $9.37 | $490,313 | Direct |
| Dec 9, 2024 | OLMA Olema Pharmaceuticals, Inc. | Award | 204,750 | - | $0 | Direct |
1-8 of 8 transactions